Evidence map›Paper›PMID 36379652›Full record

Trial reportBMJ open2022

FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial.

Puneet Plaha, Sophie Camp, Jonathan Cook, Peter McCulloch, Natalie Voets, Ruichong Ma, Martin J B Taphoorn, Linda Dirven, Matthew Grech-Sollars, Colin Watts and 12 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 5 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 5 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Utility of diffusion tensor imaging and tractography (DTI/DTT) in the surgical resection of intramedullary spinal cord tumors: A scoping review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 2 countries.

Puneet PlahaDepartment of Neursurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK puneet.plaha@ouh.nhs.uk.
Sophie CampNeurosurgery, Imperial College Healthcare NHS Trust, London, UK.
Jonathan CookOxford Clinical Trials Research Unit & Surgical Intervention Trials Unit, University of Oxford Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Oxford, Oxfordshire, UK.
Peter McCullochNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Natalie VoetsNuffield Department of Clinical Neurosciences, Oxford University, Oxford, Oxfordshire, UK.
Ruichong MaDepartment of Neursurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID 0000-0002-4939-8553
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Linda DirvenDepartment of Neurology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Matthew Grech-SollarsDepartment of Computer Sciences, UCL, London, UK.
Colin WattsInstitute of Cancer and Genomic Studies, University of Birmingham, Birmingham, UK.ORCID 0000-0003-3531-8791
Helen BulbeckBrainstrust, Cowes, UK.
Michael D JenkinsonInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, Merseyside, UK.
Matthew WilliamsDepartment of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK.
Adrian LimDepartment of Surgery and Cancer, Imperial College London, London, UK.
Luke DixonNeuroradiology, Imperial College Healthcare NHS Trust, London, UK.
Stephen John PriceNeurosurgery Division, Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.ORCID 0000-0002-7535-3009
Keyoumars AshkanDepartment of Neurosurgery, King's College Hospital, London, UK.
Vasileios ApostolopoulosDepartment of Neursurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Vicki S BarberOxford Clinical Trials Research Unit & Surgical Intervention Trials Unit, University of Oxford Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Oxford, Oxfordshire, UK.
Amy TaylorNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
FUTURE-GB collaborators
Dipankar NandiNeurosurgery, Imperial College Healthcare NHS Trust, London, UK.
Imperial College Healthcare NHS Trust · GBUniversity of Oxford · GBLeiden University Medical Center · NLNuffield Orthopaedic Centre · GBEntrust · GBKing's College Hospital · GBNational Hospital for Neurology and Neurosurgery · GBOxford University Hospitals NHS Trust · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Cambridge · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSurgery remains the mainstay for treatment of primary glioblastoma, followed by radiotherapy and chemotherapy. Current standard of care during surgery involves the intraoperative use of image-guidance and 5-aminolevulinic acid (5-ALA). There are multiple other surgical adjuncts available to the neuro-oncology surgeon. However, access to, and usage of these varies widely in UK practice, with limited evidence of their use. The aim of this trial is to investigate whether the addition of diffusion tensor imaging (DTI) and intraoperative ultrasound (iUS) to the standard of care surgery (intraoperative neuronavigation and 5-ALA) impacts on deterioration free survival (DFS). METHODS AND ANALYSIS: This is a two-stage, randomised control trial (RCT) consisting of an initial non-randomised cohort study based on the principles of the IDEAL (Idea, Development, Exploration, Assessment and Long-term follow-up) stage-IIb format, followed by a statistically powered randomised trial comparing the addition of DTI and iUS to the standard of care surgery. A total of 357 patients will be recruited for the RCT. The primary outcome is DFS, defined as the time to either 10-point deterioration in health-related quality of life scores from baseline, without subsequent reversal, progressive disease or death. ETHICS AND DISSEMINATION: The trial was registered in the Integrated Research Application System (Ref: 264482) and approved by a UK research and ethics committee (Ref: 20/LO/0840). Results will be published in a peer-reviewed journal. Further dissemination to participants, patient groups and the wider medical community will use a range of approaches to maximise impact. TRIAL REGISTRATION NUMBER: ISRCTN38834571.

Indexed as

GlioblastomaAminolevulinic AcidHumansNeuronavigationQuality of LifeUltrasonography, InterventionalAminolevulinic AcidClinical trialsNeurosurgerySURGERY

Identifiers

PMID36379652
PMCPMC9668053
OpenAlexW4309066569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.